Dual-State Luxury Addiction Treatment Operator, California & Hawaii

$4.7M

Revenue

$1.4M

SDE

Subscribe Free

Read the full deal writeup

Get Free Access

Already a member? Sign in

Full Editorial Writeup

This is a two-facility behavioral health operation running licensed residential drug and alcohol treatment programs across California and Hawaii, positioned at the luxury end of the market. The listing frames it as a dual-state platform in high-barrier destination markets, which is the polite way of saying the licensing, real estate, and location economics make it hard for a new entrant to replicate. Reported EBITDA is roughly $1.42M, and the sale includes real estate in both markets, which is a meaningful piece of the value stack and changes how you underwrite the multiple.

Addiction and behavioral health treatment sits in a demand pool that does not shrink in a downturn, and arguably grows. The luxury/private-pay and premium out-of-network angle means the customer base skews toward higher-income families willing to pay cash or fight for reimbursement, which supports pricing power but also concentrates risk in payer mix and census (bed occupancy). Two facilities in two states means two license stacks, two survey/accreditation regimes, and two local labor markets to manage.

The standout feature here is financing approval already in place plus bundled real estate, which lowers the friction for a capitalized buyer who wants to control both the operations and the underlying dirt. The tradeoff is that a chunk of the enterprise value is bricks and beds, so the buyer needs to separate the operating multiple from the real estate value to know what they are actually paying for the cash flow.

Why we like it

Behavioral health and addiction treatment is genuinely non-discretionary demand that holds or rises through recessions, and the luxury tier serves families who can pay cash or pursue out-of-network reimbursement. Reported EBITDA of about $1.42M gives you a real earnings base to underwrite against rather than a promise. That combination of essential service and premium pricing is exactly the durable cash flow profile we hunt for.
Licensing, zoning, and accreditation in residential treatment create a real moat, and the listing explicitly calls these high-barrier destination markets. Standing up a new luxury facility in California or Hawaii from scratch is a multi-year permitting and licensing grind, which protects incumbents. You are buying operational permission that money alone cannot quickly recreate.
The deal includes real estate in both states, so a buyer controls the physical assets and is not exposed to landlord renewal risk or rent escalation on the beds that generate the revenue. Owning the dirt in Hawaii and California also gives you a hard-asset floor under the purchase and optionality to refinance or sell-leaseback later. That downside protection matters when census is the main variable.
Financing is already approved, which removes one of the biggest deal-killers in a $1M-plus EBITDA acquisition and shortens time to close. Geographic diversification across two states also smooths single-market regulatory or referral-source shocks. For a capitalized operator, the deal is structured to move rather than to negotiate financing from zero.

How to improve it

Audit and optimize payer mix and reimbursement in the first 90 days, because in luxury treatment the gap between billed and collected on out-of-network claims is often the single largest lever. Bring in a specialized revenue cycle team or vendor to chase aging claims and tighten authorization workflows. Even a few points of collection improvement drops straight to EBITDA.
Measure and then push census (bed occupancy) as the primary KPI, since a treatment facility with empty beds is burning fixed cost. Build a dashboard tracking occupancy, average length of stay, and admissions by referral source so you can see the funnel clearly. Small occupancy gains on an already-fixed cost base are extremely high margin.
Invest in owned admissions and marketing channels to reduce reliance on paid referral or lead-broker dependence, which is both expensive and a compliance risk in this industry. Build organic search, alumni referral, and provider relationships so acquisition cost per admission trends down. Owned demand is the difference between a fragile and a durable P&L here.
Tighten labor scheduling and clinical staffing ratios across both facilities, since staffing is the largest operating cost and California and Hawaii are both high-wage, tight labor markets. Standardize roles and cross-train across the two sites where licensing allows. Even modest efficiency in scheduling protects margin without touching care quality.
Formalize accreditation and compliance systems (Joint Commission or CARF, state survey readiness) as a defensible asset rather than a checkbox. Clean, audited compliance both reduces shutdown risk and materially increases the exit multiple for the next buyer. Treat regulatory excellence as an investment, not a cost.
Explore adding step-down levels of care such as intensive outpatient or sober living to capture the same patient across a longer continuum. This lengthens revenue per admission and improves outcomes, which strengthens referral relationships. It also uses existing real estate and staff more fully.

Diligence notes

Revenue and true owner earnings are not disclosed, so demand three years of financials and reconcile the $1.42M EBITDA figure to tax returns and bank statements. Confirm whether that number is before or after real estate carrying costs, since the deal bundles property. You cannot separate the operating multiple from the RE value until you have this.
Scrutinize payer mix and collections in detail: what percentage is private pay versus out-of-network insurance, what are historical denial and clawback rates, and how aged is the receivables book. Luxury treatment revenue can look strong on paper while collections lag badly. Get a third-party revenue cycle review before closing.
Verify all state licenses, accreditations, and survey history in both California and Hawaii, including any past deficiencies, corrective action plans, or complaints. A lapse or restriction on either license can zero out that facility's value overnight. Confirm licenses are transferable in the contemplated transaction structure.
Analyze census (occupancy) trends monthly for the past two to three years to understand seasonality, volatility, and any COVID-era distortions. Ask specifically where admissions originate and whether the business depends on any single referral source or lead broker. Concentration in referrals is the hidden fragility in this model.
Appraise the real estate in both markets independently so you know exactly how much of the price is bricks versus operating goodwill. Confirm zoning and use permits specifically allow residential treatment at each site and are not grandfathered in a way that dies on transfer. This determines your real return on the cash flow you are buying.

Source

Originally listed on BizBuySell. View original listing →